Full Product Name
DLL3 siRNA (Mouse)
Product Synonym Names
Delta-like protein 3; Drosophila Delta homolog 3; Delta3; M-Delta-3
Product Gene Name
DLL3 sirna
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for O88516
Specificity
DLL3 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Purity/Purification
> 97%
Form/Format
Lyophilized powder
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse DLL3 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Other Notes
Small volumes of DLL3 sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
DLL3 sirna
siRNA to inhibit DLL3 expression using RNA interference
Applications Tested/Suitable for DLL3 sirna
RNA Interference (RNAi)
NCBI/Uniprot data below describe general gene information for DLL3. It may not necessarily be applicable to this product.
NCBI Accession #
NP_031892.2
[Other Products]
NCBI GenBank Nucleotide #
NM_007866.2
[Other Products]
UniProt Primary Accession #
O88516
[Other Products]
UniProt Secondary Accession #
O35675; Q80W06; Q9QWL9; Q9QWZ7[Other Products]
UniProt Related Accession #
O88516[Other Products]
Molecular Weight
61,125 Da
NCBI Official Full Name
delta-like protein 3
NCBI Official Synonym Full Names
delta-like 3 (Drosophila)
NCBI Official Symbol
Dll3 [Similar Products]
NCBI Official Synonym Symbols
pu; pudgy
[Similar Products]
NCBI Protein Information
delta-like protein 3
UniProt Protein Name
Delta-like protein 3
UniProt Synonym Protein Names
Drosophila Delta homolog 3; Delta3; M-Delta-3
Protein Family
Delta-like protein
UniProt Gene Name
Dll3 [Similar Products]
UniProt Synonym Gene Names
Delta3; M-Delta-3 [Similar Products]
UniProt Entry Name
DLL3_MOUSE
UniProt Comments for DLL3
DLL3: Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. Can bind and activate Notch-1 or another Notch receptor.
Protein type: Membrane protein, integral; Cell development/differentiation
Cellular Component: membrane; integral to membrane
Molecular Function: protein binding; Notch binding
Biological Process: compartment specification; paraxial mesoderm development; nervous system development; tissue development; Notch signaling pathway; positive regulation of neurogenesis; somitogenesis; in utero embryonic development; multicellular organismal development; negative regulation of astrocyte differentiation; negative regulation of Notch signaling pathway; cell fate determination; cell differentiation; skeletal development; negative regulation of neurogenesis
Research Articles on DLL3
1. Intriguing changes are observed in the cranio-caudal borders of multifidus muscle in mutant Dll3 and Lfng models of idiopathic scoliosis.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
